Sponsor pipeline

Astellas Pharma Inc clinical trial pipeline

Get alerts when Astellas Pharma Inc's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

3 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 2 with minor changes only.

  1. Notable

    Primary endpoint(s) modified

    Also in this update: Sponsor changed: [Redacted] to Astellas Pharma Inc; Results posted: Sep 30, 2026

    Astellas Pharma IncNot specified NCT06156696 Registry history

Show 2 trials with minor changes only
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-09-21 NCT07829653 A Study to Confirm if Fezolinetant Helps to Reduce Hot Flashes in Indian Women Going… Phase 3 Not Yet Recruiting

Active trials by phase

Phase 1
2
Phase 1/2
1
Phase 3
1
Phase 4
1

Disease areas by active trials

Colorectal Cancer (1) · Lung Cancer (1) · Non-Small Cell Lung Cancer (NSCLC) (1) · Pancreatic Cancer (1) · Stroke (1)

Get alerts when Astellas Pharma Inc's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free